Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 46 citing articles:

Myeloid-derived suppressor cells in hematological malignancies: friends or foes
Meng Lv, Ke Wang, Xiao‐Jun Huang
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 100
Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis
Eros Marín, Laurence Bouchet‐Delbos, Ophélie Renoult, et al.
Cell Metabolism (2019) Vol. 30, Iss. 6, pp. 1075-1090.e8
Open Access | Times Cited: 88
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
Shifen Wang, Xingyun Zhao, Siwen Wu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs
Rochelle Fletcher, Natália Schneider, Michael T. Patterson, et al.
Blood Advances (2023) Vol. 7, Iss. 7, pp. 1117-1129
Open Access | Times Cited: 20
Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation
Ying‐Jun Chang, Xiaosu Zhao, Xiao‐Jun Huang
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 46
Granulocyte Colony-Stimulating Factor Attenuates Renal Ischemia-Reperfusion Injury by Inducing Myeloid-Derived Suppressor Cells
Ji-Jing Yan, Jung-Hwa Ryu, Honglin Piao, et al.
Journal of the American Society of Nephrology (2020) Vol. 31, Iss. 4, pp. 731-746
Open Access | Times Cited: 42
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Shunjie Yu, Xiaotong Ren, Lijuan Li
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 28
The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
Ruiyang Ren, Chenyi Xiong, R.C-S. Ma, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 15
Region‐Specific CD16+ Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer Cells
Yan Zhang, Zi-En Wang, Yu Lu, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 6
Update of the “Beijing Protocol” haplo-identical hematopoietic stem cell transplantation
Meng Lv, Ying‐Jun Chang, Xiao‐Jun Huang
Bone Marrow Transplantation (2019) Vol. 54, Iss. S2, pp. 703-707
Closed Access | Times Cited: 36
Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation
Shuo Yang, Yunxiong Wei, Rui Sun, et al.
Cytotherapy (2020) Vol. 22, Iss. 12, pp. 718-733
Closed Access | Times Cited: 28
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
Christos Demosthenous, Ioanna Sakellari, Vassiliki Douka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2050-2050
Open Access | Times Cited: 27
Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases
Jilu Zhang, Alan W. Hodges, Shu‐Hsia Chen, et al.
Cellular Immunology (2021) Vol. 362, pp. 104300-104300
Open Access | Times Cited: 24
Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering Committee
Linda Oppizzi, Kinga Hosszu, Susan E. Prockop, et al.
Cytotherapy (2025)
Closed Access
Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation
Maud D’Aveni, Anne Béatrice Notarantonio, Allan Bertrand, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 25
Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance
Carlijn Voermans, Mette D. Hazenberg
Blood (2020) Vol. 136, Iss. 4, pp. 410-417
Open Access | Times Cited: 24
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival
John K. Wiencke, Annette M. Molinaro, Gayathri Warrier, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Haploidentical transplants with a G-CSF/ATG-based protocol: Experience from China
Zhengli Xu, Xiao‐Jun Huang
Blood Reviews (2022) Vol. 62, pp. 101035-101035
Closed Access | Times Cited: 12
Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation
Thomas F. Michniacki, Sung Won Choi, Daniel Peltier
Handbook of experimental pharmacology (2021), pp. 209-243
Open Access | Times Cited: 15
Icariin alleviates high‐fat diet‐induced nonalcoholic fatty liver disease via up‐regulating miR‐206 to mediate NF‐κB and MAPK pathways
Hang Zhao, Hongyang Tian
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 6
β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD
Hemn Mohammadpour, Joseph L. Sarow, Cameron R. MacDonald, et al.
JCI Insight (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 16
Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia
Binglei Zhang, Lingyun Chen, Jian Zhou, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity
Jasmin Scheurer, Tanja Reisser, Frank Leithäuser, et al.
Clinical & Experimental Immunology (2020) Vol. 202, Iss. 3, pp. 407-422
Open Access | Times Cited: 14
von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy
Zhenzhen Xu, Chengwei Luo, Peilong Lai, et al.
Clinical and Applied Thrombosis/Hemostasis (2020) Vol. 26, pp. 107602961989268-107602961989268
Open Access | Times Cited: 12
Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells
Min-Jung Park, Jin-Ah Baek, Se Young Kim, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top